Novartis faces questions about proxy voting independence
At the Novartis general assembly meeting last year.
Keystone / Anthony Anex
A media investigation has revealed that proxy votes submitted by shareholders ended up at Novartis headquarters instead of the elected representative ahead of the annual general meeting.
This content was published on
1 minute
swissinfo.ch/ac
Novartis shareholders that choose to vote via proxy ahead of the Annual General Meeting were under the assumption that their votes are sent to a Basel lawyer, who is their elected representative.
The Swiss public television SRF programme “RundschauExternal link” tracked the envelopes containing votes via GPS trackers and found that they were diverted and sent to Novartis headquarters instead. This means that Novartis can see the name of shareholders and their voting positions ahead of the shareholder meeting, indicated SRF on Wednesday.
The revelation drew criticism from Thomas Minder, the initiator of the 2013 executive pay cap “Minder” initiative, who said that “If we take a voting fight or an election for the board of directors, then the board of directors can still mobilise for their side [ahead of the General Meeting] – that will not work”.
Novartis responded to questions saying, “it is important to note that our procedure is consistent with applicable law and does not affect the independence of the independent proxy because votes are counted under its supervision.” However, the company said that it would use the information from the investigation to improve its procedures.
More
More
Swiss firms face greater shareholder opposition
This content was published on
Shareholder rebellion over executive pay at Credit Suisse earlier this year is just one example of growing dissent by Swiss company owners.
Train vs plane: would you take a direct train between London and Geneva?
Eurostar is planning to run direct trains from Britain to Germany and Switzerland from the early 2030s. Would you favour the train over the plane? If not, why not?
Prevention and tech could help save billions on Swiss healthcare costs, says Deloitte
This content was published on
By focusing on prevention and technology, it would be possible to reduce Switzerland's healthcare bill by CHF30 billion a year by 2040, according to Deloitte Switzerland.
Environment director warns of increasing climate-related risks in Switzerland
This content was published on
The director of the Swiss Federal Office for the Environment (FOEN) has warned of increasing climate-related risks in Switzerland in an interview with SonntagsBlick on Sunday.
Gotthard traffic queue hits 11km at start of holiday season
This content was published on
The start of the summer holidays saw a long traffic jam in front of the Gotthard tunnel on Saturday. Traffic jams between Erstfeld and Göschenen in canton Uri were up to 11 kilometres long early in the morning.
This content was published on
The water temperature of the Rhine River could rise by up to 4.2° degrees Celsius by the end of the century due to the warming planet, scientists warn.
This content was published on
The Federal Council wants to explore the possibilities of joining the European Union’s €800-billion rearmament programme without compromising Swiss neutrality.
Defence Minister Pfister stresses importance of Swiss mission in Balkans
This content was published on
During a visit to the Balkans region last week, Swiss Defence Minister Martin Pfister met Swisscoy peacekeeping troops in Kosovo.
Premiere for Swiss Air Force on French National Day
This content was published on
On July 14, the Swiss Air Force will take part in the traditional air parade in Paris to mark the French bank holidays with an F/A-18 fighter jet. This is a first for Switzerland.
Swiss launch competition for memorial to Nazi victims
This content was published on
The victims of Nazi Germany are to be commemorated on the Casinoterrasse in Bern. A competition will be held to determine what the site will look like.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Novartis stockpiles drugs in UK to ensure supply
This content was published on
Swiss pharmaceuticals giant Novartis says a no-deal Brexit could hurt patients and that it is stockpiling medicines in the UK to help ensure supply.
This content was published on
Around 1,500 jobs are affected in production and 700 in services. Novartis currently employs 13,000 people across Switzerland.
This content was published on
UBS shareholders have overwhelmingly approved executive bonuses at the bank’s AGM. Why such a difference from Credit Suisse?
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.